Roxana
Jijie
ab,
Tetiana
Dumych
c,
Li
Chengnan
a,
Julie
Bouckaert
c,
Kostiantyn
Turcheniuk
a,
Charles-Henri
Hage
df,
Laurent
Heliot
df,
Benoit
Cudennec
e,
Nicoleta
Dumitrascu
b,
Rabah
Boukherroub
a and
Sabine
Szunerits
*a
aInstitut d'Electronique, de Microélectronique et de Nanotechnologie (IEMN), UMR CNRS8520, Université Lille1, Avenue Poincaré-BP 60069, 59652 Villeneuve d'Ascq, France. E-mail: sabine.szunerits@univ-lille1.fr
bIasi Plasma Advanced Research Center (IPARC), Faculty of Physics, Alexandru Ioan Cuza University of Iasi, Bd. Carol I No. 11, Iasi 700506, Romania
cUnité de Glycobiologie Structurale et Fonctionnelle (UGSF), Université Lille 1, CNRS UMR 8576, 59655 Villeneuve d'Ascq, France
dLaboratoire de physique des Lasers, Atomes et Molécules (PhLAM), Université Lille 1, CNRS UMR 8523, 59655 Villeneuve d'Ascq, France
eInstitut Charles Viollette, Polytech'Lille, Université Lille 1, Avenue Paul Langevin, 59655 Villeneuve d'Ascq, France
fInstitut de Recherche XLIM, UMR CNRS 7252, 123, Avenue Albert Thomas, 87060 Limoges, France
First published on 5th December 2024
Expression of concern for ‘Particle-based photodynamic therapy based on indocyanine green modified plasmonic nanostructures for inactivation of a Crohn's disease-associated Escherichia coli strain’ by Roxana Jijie et al., J. Mater. Chem. B, 2016, 4, 2598–2605, https://doi.org/10.1039/C5TB02697K.
An expression of concern will continue to be associated with the article until we receive conclusive evidence regarding the reliability of the reported data.
Michaela Mühlberg
14th November 2024
Executive Editor, Journal of Materials Chemistry B
This journal is © The Royal Society of Chemistry 2025 |